BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/16/2014 11:44:00 AM | Browse: 1118 | Download: 1160
 |
Received |
|
2012-08-23 09:53 |
 |
Peer-Review Started |
|
2012-08-23 13:33 |
 |
To Make the First Decision |
|
|
 |
Return for Revision |
|
|
 |
Revised |
|
2012-11-18 13:14 |
 |
Second Decision |
|
2013-02-08 09:35 |
 |
Accepted by Journal Editor-in-Chief |
|
|
 |
Accepted by Executive Editor-in-Chief |
|
2013-02-08 11:20 |
 |
Articles in Press |
|
|
 |
Publication Fee Transferred |
|
|
 |
Edit the Manuscript by Language Editor |
|
2013-03-13 10:12 |
 |
Typeset the Manuscript |
|
2013-04-20 13:27 |
 |
Publish the Manuscript Online |
|
2013-05-07 10:53 |
Category |
Gastroenterology & Hepatology |
Manuscript Type |
Autobiography |
Article Title |
Expression of interleukin-22/STAT3 signaling pathway in ulcerative colitis and related carcinogenesis
|
Manuscript Source |
Invited Manuscript |
All Author List |
Lian-Zhen Yu, Hai-Yang Wang, Shu-Ping Yang, Zhi-Ping Yuan, Fang-Yuan Xu, Chao Sun and Rui-Hua Shi |
Funding Agency and Grant Number |
Funding Agency |
Grant Number |
National Natural Science Foundation of China |
81072692 |
Natural Science Foundation of Jiangsu Higher Education Institutions of China |
10KJB320007 |
|
Corresponding Author |
Rui-Hua Shi, MD, PhD, Department of Gastroenterology, First Affiliated Hospital of Nanjing Medical University, 300 Guangzhou Road, Nanjing 210029, Jiangsu Province, China. ruihuashi@126.com
|
Key Words |
Ulcerative colitis; Ulcerative colitis-related carcinogenesis; Interleukin-22; Interleukin-22R1; STAT3 |
Core Tip |
This study investigates the expression of interleukin (IL)-22, IL-22R1, IL-23, and STAT3 in ulcerative colitis (UC) and UC-related carcinogenesis (UC-CRC) tissues from human and mouse. The results showed that IL-22 and related proteins were closely related to the severity of colitis, and the expression level of IL-22 and related proteins was higher in dysplasia tissues. IL-22/STAT3 signaling pathway was related to UC and UC-CRC. IL-22 can be used as a biomarker for determining the severity of UC and as an interesting therapeutic target in active UC and UC-CRC.
|
Publish Date |
2013-05-07 10:53 |
Citation |
Yu LZ, Wang HY, Yang SP, Yuan ZP, Xu FY, Sun C, Shi RH. Expression of interleukin-22/STAT3 signaling pathway in ulcerative colitis and related carcinogenesis. World J Gastroenterol 2013; 19(17): 2638-2649 |
URL |
http://www.wjgnet.com/1007-9327/full/v19/i17/2638.htm |
DOI |
http://dx.doi.org/10.3748/wjg.v19.i17.2638 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345